Skip to contentN
NEUROONE MEDICAL TECHNOLOGIES Corp
N
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp Q1 2026 · 10-Q
Revenue$2.89M$2.89M−11.7% vs Q1 2025 Net Income-$1.44M-$1.44MN/M vs Q1 2025 EPS Diluted-$0.03-$0.03N/M vs Q1 2025 Gross Profit$1,567,828−18.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NEUROONE MEDICAL TECHNOLOGIES Corp · CIK 1500198 · Engraved from SEC EDGAR
Operating Cash Flow-$3,115,835N/M Free Cash Flowderived-$3,156,589N/M Margins · derivedGross margin54.2%−4.7 pt vs Q1 2025
Operating margin-59.0%−111.3 pt vs Q1 2025
Net margin-49.7%−104.2 pt vs Q1 2025
ended Dec 31, 2025 · filed Feb 17, 2026 · 48 d after period end